Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools
RSS SUMMARY · AGGREGATED FROM TWSJ
The deal seeks to bolster the artificial-intelligence offerings of Roche’s diagnostics division and to help accelerate clinical-therapy development.
The deal seeks to bolster the artificial-intelligence offerings of Roche’s diagnostics division and to help accelerate clinical-therapy development.
The deal seeks to bolster the artificial-intelligence offerings of Roche’s diagnostics division and to help accelerate clinical-therapy development.
Continue Reading
The full story continues on The Wall Street Journal.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
TWSJ
World News
Israel Built and Defended a Secret Iran War Base in Iraq
TWSJ·3h ago·3 min read
Tech
For Palantir, AI Is a Product, a Punching Bag—and a Problem
TWSJ·5h ago·3 min read
World News
The Hunter-Gatherers Weighing Whether to Join the Modern World
TWSJ·6h ago·3 min read
Business
Person Struck and Killed by Plane on Runway at Denver Airport
TWSJ·7h ago·3 min read
Related
On this beat
Business
American Airlines sees $341 million hike in Q1 jet fuel costs
THE STREET·1h ago·3 min read
Business
How Maury Povich Outlasted the Daytime TV Wars Using This 1 Business Framework
INC·2h ago·3 min read
Business
A nutritionist stocks up on 12 ingredients to effortlessly add protein, fiber, and vitamins to his meals
BI·1h ago·3 min read
Business
BofA’s blunt call on Planet Fitness stock price after earnings
THE STREET·1h ago·3 min read